← All trials
NCT01603667
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2012
- Primary completion
- Oct 1, 2015
- Completion date
- Oct 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 86
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- China Medical UniversityLead sponsor
- Shin Kong Wu Ho-Su Memorial HospitalCollaborator
- Changhua Christian HospitalCollaborator
- Kaohsiung Medical UniversityCollaborator
- Kuang Tien General HospitalCollaborator
- Chung Shan Medical UniversityCollaborator
- Cheng Hsin Rehabilitation Medical CenterCollaborator
- National Taiwan UniversityCollaborator
- Government of TaiwanCollaborator
- En Chu Kong HospitalCollaborator
- Taipei Medical UniversityCollaborator
- Taichung Veterans General HospitalCollaborator
- National Cheng Kung UniversityCollaborator
- China Medical UniversityOverall official - principal investigator
- Taipei Veteran General hospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.